Aktienanalyse zu CME Group Inc (CME)CMECME Group Inc

CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives. It operates in the Financials sector (SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & industry).

CME Group Inc is currently priced at $285.80, which is close to the recent analyst target of $270 from Deutsche Bank, suggesting limited upside potential. The RSI is at 81.3, indicating that the stock is overbought, which may lead to a price correction. Additionally, the stock has shown a 5-day change of +3.93% and a year-to-date change of +5.98%, reflecting recent momentum, but the mixed analyst ratings indicate caution. The main risk is the downgrade from Deutsche Bank, which suggests that the stock may not have much room to grow in the short term.

14 analysts cover CME: 9 rate it Buy, 5 Hold and 0 Sell. The average price target is 285.90.